Soluble receptor BR43x2 and methods of using
OwnerJane Gross, Wenfeng Xu +2inventors
InventorsJane Gross, Wenfeng Xu, Karen Madden, David Yee
Life of this patent
Estimating the term…
Abstract
Soluble, secreted tumor necrosis factor receptor polypeptides, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed. The polypeptides comprise one cysteine-rich repeat that is homologous to other tumor necrosis factor receptors, such as transmembrane activator and CAML-interactor (TACI). The polypeptides may be used for detecting ligands, agonists and antagonists. The polypeptides may also be used in methods that modulate B cell activation.
Claims3
1-63. (canceled)
A method of inhibiting TACI activity, BCMA activity, or both in a mammal, which comprises administering a specific binding partner for APRIL, wherein said specific binding partner comprises a TACI/BCMA extracellular consensus sequence (SEQ ID NO:13) covalently attached to a vehicle.
Dependencies are inferred from the claim text.